About Four 20 Pharma GmbH
At the heart of Four 20 Pharma's mission is a steadfast commitment to providing the best possible medical care for patients through high-quality medicinal cannabis. Founded in 2018 in Paderborn, Germany, the company has rapidly established itself as a market and quality leader within the German medical cannabis sector. This dedication is rooted in a culture of quality, patient well-being, and service. The team at Four 20 Pharma sees themselves as part of an innovative force shaping the future of the industry, operating within a dynamic and supportive work environment. They believe in the therapeutic potential of the cannabis plant and are driven to make it accessible to patients who can benefit from it, aiming to improve their quality of life. This vision is upheld by adhering to the most stringent pharmaceutical standards, including EU-GMP (Good Manufacturing Practice) and GDP (Good Distribution Practice) certifications, ensuring the highest and most consistent quality across the entire supply chain.
The company's culture is built on a foundation of transparency and reliability, positioning itself as a trusted partner for doctors, pharmacists, medical facilities, and patients. By creating a robust network of carefully selected suppliers and logistics partners who also meet GMP and GDP standards, Four 20 Pharma guarantees the integrity and traceability of its products, from cultivation to delivery. This meticulous approach began with the founders, Thomas Schatton and Torsten Greif, who personally vetted cultivators to find partners that shared their commitment to excellence. Now a subsidiary of Curaleaf Holdings, Four 20 Pharma continues to expand its influence, driven by a team that is passionate about education and destigmatizing medical cannabis. They foster a collaborative atmosphere where employees are encouraged to contribute to the company's growth and the broader evolution of the medical cannabis field, ensuring that patients receive not just a product, but a promise of quality and continuous care.
FAQs
- When was Four 20 Pharma GmbH founded?
- Four 20 Pharma GmbH was founded in 2018.
- Who is the CEO of Four 20 Pharma GmbH?
- The CEOs are Thomas Schatton, Torsten Greif.
- What industries or markets does Four 20 Pharma GmbH operate in?
- Four 20 Pharma GmbH operates in the following markets: Medical Cannabis, Healthcare, Biotechnology, Cannabis Industry, Life Sciences, Supply Chain Management, Health and Wellness, Regulated Substances, European Healthcare Market, and Pharmaceutical.
- How many employees does Four 20 Pharma GmbH have?
- Four 20 Pharma GmbH has 51-200 employees.
- Where does Four 20 Pharma GmbH have employees?
- Four 20 Pharma GmbH has employees in Germany.
- Does Four 20 Pharma GmbH support remote work or working from home?
- Yes, Four 20 Pharma GmbH is a remote-friendly company.
- What employee benefits does Four 20 Pharma GmbH offer?
- Four 20 Pharma GmbH provides 9 benefits to their employees.
- Does Four 20 Pharma GmbH offer a four-day work week?
- No, Four 20 Pharma GmbH does not offer a four-day work week.
- What is Four 20 Pharma GmbH's website?
- Four 20 Pharma GmbH's website is 420pharma.com.
